Semaglutide, a second-generation GLP-1 agonist, achieved around 14% total body weight loss in clinical trials, while tirzepatide, a dual GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, has demonstrated even more impressive results, with average weight loss reaching 22.5%
Make Simple Dietary Changes What you eat plays a major role in digestive health
For a detailed comparison, the semaglutide versus tirzepatide comparison page provides a complete breakdown
Rather than sourcing two pens as separate orders with separate dispatch windows, potential batch differences, and independent cold-chain risks the Retatrutide 20mg x2 Bundle delivers both pens together, from one batch, in one cold-chain-controlled shipment
GLP-1GLP-1GLP-1 3
Additional screening and caution considerations Other medical situations that require careful evaluation include: History of pancreatitis GLP-1 receptor agonists are generally used with caution in people with a history of treated pancreatitis